Hip Replacements News
Massive Hip Recalls Cause Financial Setbacks for Johnson & Johnson, Stryker
Hip implant recalls cost orthopaedic manufacturing companies Stryker and Johnson & Johnson millions of dollars so far in 2013, according to first-quarter earnings reports by the companies. Stryker Corporation’s report of quarterly net earnings includes a $40 million charge related to the 2012 voluntary recall of its Rejuvenate and ABG II Modular-Neck Hip Stems, hiking [...]
Jury Sides with Johnson & Johnson in Second DePuy ASR Hip Implant Trial
An Illinois jury ruled in favor of Johnson & Johnson in the second trial alleging that defects in the DePuy ASR hip implant caused the device to fail at unacceptably high rates. DePuy Orthopaedics, a division of Johnson & Johnson, issued a voluntary recall for the ASR XL Acetabular Hip System in August 2010. The [...]
Metal-on-Metal Hip Implant Pain Linked to Tissue Damage, Study Shows
Unexplained pain in patients with metal-on-metal (MoM) implants is more often an indication of tissue damage rather than implant wear, according to researchers from the Hospital for Special Surgery (HSS). Dr. Danyal Nawabi and his colleagues from HSS presented their findings in Chicago during the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) [...]
Johnson & Johnson, Stryker in Hot Water after Hip Implant Recalls
A look at the top hip implant new stories this week includes: new information shows the DePuy ASR hip was recalled for failing to meet “clinical expectations”; the Food and Drug Administration sends a warning letter to Stryker; and a new study shows levels of metal ions in the blood may predict hip implant failure. [...]
J&J Ordered to Pay $8.3M in First DePuy ASR Hip Implant Trial
The jury in the first of 10,750 DePuy ASR hip lawsuits to go to trial awarded a Montana man $8.3 million and found Johnson & Johnson negligent for designing a defective implant, The New York Times reported. The panel ordered the billion-dollar medical company to pay the plaintiff, Loren Kransky, $338,000 for medical expenses and [...]
Stricter Regulations Come Too Late for Patients with Stryker Hips
The U.S. Food and Drug Administration (FDA) has proposed changes to regulations that allowed two Stryker Corp. recalled hip implant systems to be deemed safe. But the move does little for the tens of thousands of patients already implanted with the faulty medical devices. In a recent Proposed Rule published in the U.S. government’s Federal [...]